DENA BELL: Open Payments
NPI 1346672573 · BEAVERCREEK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 26 payments from 8 companies in 2025. Trend: 2023 $1,011 · 2024 $2,909 · 2025 $851
Food & beverage: $762Education: $89
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $390 |
| GlaxoSmithKline, LLC. | 4 | $147 |
| SANOFI-AVENTIS U.S. LLC | 1 | $89 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| GENZYME CORPORATION | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Blueprint Medicines Corporation | 1 | $22 |
| BioCryst US Sales Co., LLC | 1 | $18 |
Products named: FASENRA, DUPIXENT, NUCALA, TEZSPIRE, Rhapsido, AIRSUPRA, AYVAKIT, ORLADEYO.
Industry payments across OH — which companies pay providers there.
